PartsTable TECHNICAL DATA SHEET
JULY 2026Technical Data Sheet

NDC00074-4341-19Levothyroxine Sodium Tablets

Abbvie Inc · NSN 6505-01-099-9794 · FSC 6505 · No Item Name Available
Verified by PartsTable
NSN 6505-01-099-9794 — this item is cataloged by the U.S. Government under National Stock Number 6505-01-099-9794. Primary manufacturer part number: NDC00074-4341-19.
Features
  • Levothyroxine Sodium Tablets — FSC 6505
  • Medical Designation and Grade: UNITED STATES PHARMACOPEIA
  • Primary Container Content Quantity: 1000.000 TABLETS
  • Primary Container Type: BOTTLE
  • Active Medicament Medicinal Strength: 0.025 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
  • 2 verified cross-references
  • Primary manufacturer: Abbvie Inc
Applications
  • Industrial maintenance and repair
  • Government and military logistics
  • Equipment overhaul and refurbishment
General Description

The Levothyroxine Sodium Tablets, cataloged under National Stock Number 6505-01-099-9794, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Abbvie Inc. Government technical data includes 4 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 2 commercial cross-references from 1 manufacturer, enabling identification through both NSN and commercial part number lookups. 12 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Cancelled. Unit of issue: BT.

Technical Specifications
ParameterValue
NSN6505-01-099-9794
Primary Part NumberNDC00074-4341-19
Item NameLevothyroxine Sodium Tablets
FSC / FSG6505 / 65 — No Item Name Available
ManufacturerAbbvie Inc
StatusCANCELLED
Medical Designation and GradeUNITED STATES PHARMACOPEIA
Primary Container Content Quantity1000.000 TABLETS
Primary Container TypeBOTTLE
Active Medicament Medicinal Strength0.025 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
Lifecycle & Compliance
Acquisition StatusCANCELLED
HAZMATNo
Unit of IssueBT
Verified Substitutes 12
6505-00-915-1630NDC00048-1140-03 INTERCHANGEABLE
Levothyroxine Sodium Tablets
Abbott Laboratories Inc. Div Hospital Products Division
6505-00-990-2021 INTERCHANGEABLE
Levothyroxine Sodium Tablets
6505-01-042-9260NDC00074-6624-19 INTERCHANGEABLE
Levothyroxine Sodium Tablets
Abbvie Us Llc
6505-01-094-1636NDC00048-1040-05 INTERCHANGEABLE
Levothyroxine Sodium Tablets
Baxter Healthcare Corp IV Systems/gov Sales
6505-01-153-3338NDC00378-1815-10 INTERCHANGEABLE
Levothyroxine Sodium Tablets
Mylan Pharmaceuticals Inc
6505-01-178-3941NDC00048-1090-13 INTERCHANGEABLE
Levothyroxine Sodium Tablets
Baxter Healthcare Corp IV Systems/gov Sales
6505-01-212-77183P1095 INTERCHANGEABLE
Levothyroxine Sodium Tablets
Baxter Healthcare Corp IV Systems/gov Sales
6505-01-290-8735NDC00074-4552-19 INTERCHANGEABLE
Levothyroxine Sodium Tablets
Abbvie Us Llc
6505-01-323-4605NDC00074-7068-19 INTERCHANGEABLE
Levothyroxine Sodium Tablets
Abbvie Us Llc
6505-01-351-0918NDC00048-1020-03 INTERCHANGEABLE
Levothyroxine Sodium Tablets
Abbott Laboratories Inc. Div Hospital Products Division
Cross-Reference Index
Part NumberManufacturer
SYNTHROID Abbvie Inc (USA)
NDC00074-4341-19 PRIMARY Abbvie Inc (USA)
Related Parts
6505-00-915-1630INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC00048-1140-03
6505-00-990-2021INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
6505-01-042-9260INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC00074-6624-19
6505-01-094-1636INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC00048-1040-05
6505-01-153-3338INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC00378-1815-10
6505-01-178-3941INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC00048-1090-13
6505-01-212-7718INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
3P1095
6505-01-290-8735INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC00074-4552-19
6505-01-323-4605INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC00074-7068-19
6505-01-351-0918INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC00048-1020-03
6505-01-366-0962INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC00074-5182-19
6505-01-596-5245INTERCHANGEABLE
LEVOTHYROXINE SODIUM TABLETS
NDC00074-4552-90

Frequently Asked Questions

What is NSN 6505-01-099-9794?

NSN 6505-01-099-9794 is a Levothyroxine Sodium Tablets, manufactured by Abbvie Inc, classified under FSC 6505 (No Item Name Available). Status: cancelled.

What are the part numbers for NSN 6505-01-099-9794?

NSN 6505-01-099-9794 has 2 cross-referenced part numbers: SYNTHROID (Abbvie Inc), NDC00074-4341-19 (Abbvie Inc).

What NSN replaces 6505-01-099-9794?

There are 12 known substitutes for 6505-01-099-9794: 6505-00-915-1630, 6505-00-990-2021, 6505-01-042-9260 and 9 more. Verify interchangeability with system specifications before substitution.

What are the specifications of NDC00074-4341-19?

Key specifications for NDC00074-4341-19: Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Content Quantity: 1000.000 TABLETS; Primary Container Type: BOTTLE; Active Medicament Medicinal Strength: 0.025 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT. 5 total characteristics are documented in the Federal Logistics Information System.

Is NSN 6505-01-099-9794 still in active supply?

NSN 6505-01-099-9794 is currently cancelled. Check with the Defense Logistics Agency for current availability and authorized substitutes.

Validated with multiple authoritative sources, including Government, OEM, and Certified sources.
PartsTable Design LLC · partstable.com